AzTrials
AzTrials

Gingival RecessionNCT06146855

Amnion Membrane Versus DFGG Using the Tunneling Technique in Management of Gingival Recession Defects.

A study testing Tunneling procedure with Amnion Membrane and Tunneling procedure with De-epithelialized Free Gingival Graft in people with Gingival Recession, run by Cairo University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Treatment of gingival recession is indicated mainly for esthetic reasons and keratinized tissue augmentation (Zucchelli and Mounssif, 2015). An array of surgical techniques has been proposed by the literature to cover gingival recession defects with well-documented successful outcomes. Read more about this study

Who is it for?
Ages 18 to 60 yearsHealthy volunteers can take part
Conditions the study is for
Gingival Recession
What is being tested?
Tunneling procedure with Amnion Membrane and Tunneling procedure with De-epithelialized Free Gingival Graft
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
22 participants
Where
1 siteEgypt
Study dates
5 Feb 2024to 1 Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Age between 18 and 60 years.
  • Periodontally and systemically healthy.
  • Presence of RT1 or RT2 buccal gingival recession defects ≥2 mm in depth.
  • Full-mouth plaque and bleeding score of <15% and no probing depths >3 mm.
  • Absence of non-carious cervical lesions (NCCLs) and non-detectable cemento-enamel junction (CEJ) at the defect sites.

Who cannot join

  • RT3 recession defects.
  • Smokers as smoking is a contraindication for any plastic periodontal surgery (Khuller, 2009).
  • Presence of caries lesions or restorations in the cervical area.
  • Intake of medications which impede periodontal tissue health and healing.
  • Medical contraindications for periodontal surgical procedures.
  • Uncooperative patients not willing to complete the follow up period.
  • Pregnancy and lactation.

Trial locations and contacts

1 site in 1 country.

Egypt1 site, 1 recruiting
  • Faculty of Oral and Dental Medicine

    Cairo, 12114

    Mohamed Mashaly, Bsc, 00201226442241, mohamed.mashaly@dentistry.cu.edu.eg

    Recruiting

Other trials in Egypt

About this study

Official title: Amnion Membrane as a Soft Tissue Substitute Versus De- Epithelialized Free Gingival Graft Using the Tunneling Technique in Management of Gingival Recession Defects: A Randomized Controlled Clinical Trial.

Treatment of gingival recession is indicated mainly for esthetic reasons and keratinized tissue augmentation (Zucchelli and Mounssif, 2015). An array of surgical techniques has been proposed by the literature to cover gingival recession defects with well-documented successful outcomes. The selection of one technique over the other depends on many factors. Some of these factors are related to the gingival recession defect itself, others are related to the anatomy of the palatal fibromucosa, or related to the patient variabilities (Zucchelli and De Sanctis, 2000).

Controversy exists in the literature regarding the patient morbidity after connective tissue graft harvesting. Inconclusive postulations have been made about the post-operative patient morbidity outcomes and root coverage outcomes when comparing connective tissue graft harvesting in comparison to allograft membranes used for root coverage.

Read more

The use of connective tissue graft in combination with root coverage techniques remain the gold standard for root coverage procedures. The problem with the connective tissue graft is that harvesting a graft from the palate increases morbidity, needs an extra surgical site which is more traumatic for the patient, depends on the donor tissue which could be limited, increases surgical chair-time and needs increased surgical skills (Cortellini \& Pini Prato 2012).

The rationale behind the use of amnion membrane is to avoid the morbidity inherent with connective tissue graft harvesting.

Being tested
Tunneling procedure with Amnion Membrane, Tunneling procedure with De-epithelialized Free Gingival Graft
Medical subject headings
Gingival Recession

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Tunneling procedure with Amnion MembraneProcedure or surgery

    Root Coverage by tunneling procedure with the addition of Amnion Membrane as a soft tissue substitute

  • Tunneling procedure with De-epithelialized Free Gingival GraftProcedure or surgery

    Root Coverage by tunneling procedure with the addition of De-epithelialized Free Gingival Graft

Study groups in NCT06146855
Study groupRoleWhat they receive
Tunneling with amnion membraneExperimentalNot described
Receives: Procedure: Tunneling procedure with Amnion Membrane
Tunneling with De-epithelialized Free Gingival GraftActive comparatorNot described
Receives: Procedure: Tunneling procedure with De-epithelialized Free Gingival Graft

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Recession depth

    Measured from the CEJ to the most apical extension of the gingival margin.

    Measured: 3-6 month

Secondary outcomes (8)
  1. Recession width

    Measured horizontally between the borders of the recession.

    Measured: 3-6 month

  2. Percentage of root coverage

    (Preoperative vertical recession - Postoperative vertical recession/preoperative vertical recession) x 100.

    Measured: 6 months

  3. Root coverage esthetic score

    Based on Cairo et al., (2009) the root coverage esthetic score (RES) system evaluated five variables 6 months following surgery: gingival margin (GM), marginal tissue contour (MTC), soft tissue texture (STT), MGJ alignment, and gingival color (GC).

    Measured: 6 months

  4. Gingival Thickness

    Determined 2 mm apical to the gingival margin with a short needle for anesthesia and a 3 mm diameter silicon disk stop. The needle is inserted perpendicular to the mucosal surface, through the soft tissues with light pressure until a hard surface is felt. The silicon disk stop is then placed in tight contact with the soft tissue surface with the coronal border overlapping the soft tissue margin. As the needle is located in the center of the silicon disk, measurement of GT is performed 2 mm apical from the gingival margin. After careful removal of the needle, the penetration depth is measured with a caliper accurate to the nearest 0.1 mm (Paolantonio et al., 2002; da Silva et al., 2004; Joly et al., 2007).

    Measured: 3-6 months

  5. Keratinized tissue width

    Measured as the distance between the gingival margin and the mucogingival junction (MGJ).

    Measured: 3-6 months

  6. Post-Operative Pain

    Visual Analogue Scale (VAS) with numbers from 0 to 10 ('no pain' to 'worst pain imaginable') measured daily for the first week postoperatively.

    Measured: 1 week

  7. Post-Surgical Patient Satisfaction

    A 3-item questionnaire is asked and the patients shall use a 7- point answer scale. (Kiyak et al., 1984)

    Measured: 1 week

  8. Surgical time

    Total time of the surgical procedure measured using a stopwatch.

    Measured: intraoperative

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Nov 2023
  2. Study start5 Feb 2024
  3. Primary completion1 Dec 2024 (estimated)
  4. Study completion1 Dec 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
22 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06146855
Sponsor's protocol ID
AMvsDFGG
Status last verified
Feb 2024
First submitted
18 Nov 2023
Last updated
13 Feb 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Publications

  • Bakhishov H, Isler SC, Bozyel B, Yildirim B, Tekindal MA, Ozdemir B. De-epithelialized gingival graft versus subepithelial connective tissue graft in the treatment of multiple adjacent gingival recessions using the tunnel technique: 1-year results of a randomized clinical trial. J Clin Periodontol. 2021 Jul;48(7):970-983. doi: 10.1111/jcpe.13452. Epub 2021 Apr 7.

    PubMed 33751615
  • Ghahroudi AA, Khorsand A, Rokn AR, Sabounchi SS, Shayesteh YS, Soolari A. Comparison of amnion allograft with connective tissue graft for root coverage procedures: a double-blind, randomized, controlled clinical trial. J Int Acad Periodontol. 2013 Oct;15(4):101-12.

    PubMed 24364174

Questions about this trial

What is this clinical trial studying?

A study testing Tunneling procedure with Amnion Membrane and Tunneling procedure with De-epithelialized Free Gingival Graft in people with Gingival Recession, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 13 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Mohamed Mashaly, MSc (00201226442241, mohamed.mashaly@dentistry.cu.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Recession depth (time frame: 3-6 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06146855, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Feb 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT06146855 | AzTrials